The post-genomic and Big Data era in pharmaceutical science is one of rapid and exciting change. Research avenues for pharmaceutical scientists?from drug discovery to delivery to response?are wide open, driven by the completion of the Human Genome Project, Next Generation Sequencing (NGS) technology and Big-Data computational capability. At the forefront of this new era of molecular and cellular pharmaceutics is the graduate program in pharmaceutical science at Rutgers? Ernest Mario School of Pharmacy, ranked among the top programs in this field in the 2010 National Research Council (NRC) ratings.